COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

Bleeding Management and Use of Anticoagulants: Panel Discussion

PERT Consortium 2021

G. Piazza, M. McDaniel, M. Huisman, D. Siegal, C. Pollack

COVID-19 & ICU FAQ Answered: When Should We Intubate & How Do We Adj…

Hassan Bencheqroun MD FCCP

ECG Interpretation: Everything You Need to Know to Understand and In…

Houston Methodist DeBakey Heart and Vascular Center

A. Dave

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

CHEST 2021: Patient With Intermediate Risk-PE Should Go for Thrombol…

CHEST 2021 Coverage

B. Dalal

Pulmonary Embolism During Pregnancy

Pulmonary Embolism 2016

J. Bartholomew

Cardiac PET Explains Angina: Physiologic Motifs and Mechanisms

Yale School of Medicine

N. Johnson

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

TCT 2022 Conference Coverage

W. Jaber

Extended Anticoagulation for VTE

Jeffrey Weitz

Long Term Anticoagulation - How and For How Long?

Pulmonary Embolism Symposium (PERT 2017)

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Mount Sinai Endovascular Fellows Course

J. Giri

Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Right Heart Failure Secondary to Non-Group 1 PH

Mayo Clinic Pulmonary and Critical Care Educational Series

H. Cajigas

Pulmonary Manifestations of SLE: An Update

Keck School of Medicine of USC

F. Quismorio

CHEST 2021: Diagnosing Acute Pulmonary Embolism in Pregnancy

CHEST 2021 Coverage

L. K Moores

Building on the Triangle of Trust: the Ideal of Physiologic Perfusion

The Texas Heart Institute

C. Fraser

Pulmonary Embolism: Risk Stratification and Management

Talal Dahhan